Stereotactic ablative radiotherapy as single treatment for early stage non‐small cell lung cancer: A single institution analysis

Stereotactic ablative radiotherapy as single treatment for early stage non‐small cell lung cancer: A single institution analysis

Abstract Background Stereotactic ablative radiotherapy (SABR) is the current standard‐of‐care in cases of inoperable early stage non‐small cell lung cancer (ES‐NSCLC). This study aimed to assess the survival outcomes and recurrence patterns after SABR for ES‐NSCLC in a hospital setting. Methods A si...

Full description

Bibliographic Details
Main Authors: Xiaoli Zheng, Yanan Sun, Ke Ye, Chengcheng Fan, Xiaohui Wang, Yang Yang, Ruidi Jiao, Hong Ge
Format: Article
Language:English
Published: Wiley 2021-03-01
Series:Thoracic Cancer
Subjects:
ES‐NSCLC
recurrence
SABR/SBRT
survival
Online Access:https://doi.org/10.1111/1759-7714.13768

Internet

https://doi.org/10.1111/1759-7714.13768

Similar Items